BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 

Thursday, April 24, 2014
 
Drugmaker Pharma Pac Lays Off Most Of Its Remaining Employees    More...

McKesson Pharmaceutical (MCK) Hiring 40 By Summer    More...

FDA Approves Janssen Biotech Inc. (JNJ)'s SYLVANT™ For Rare Castleman's Disease    More...

Novartis AG (NVS) Deal Makes GlaxoSmithKline (GSK)'s Pennsylvania Staffers Nervous    More...

Allergan Inc. (AGN) Curls Up Into Poison-Pill Position In Wake Of Valeant Pharmaceuticals International (VRX), Ackman Acquisition Bid    More...

After 23andMe, Inc.'s Setback, Another Silicon Valley Startup Hopes To Advance Genomics    More...

Spectrum Pharmaceuticals, Inc. (SPPI)' s Cancer Drug Melphalan Meets Main Goal In Pivotal Trial    More...

AstraZeneca PLC (AZN) Finally Rids Delaware Site For Approximately $44 Million    More...

 
More Breaking News



 
Novartis AG (NVS), GlaxoSmithKline (GSK) Reshape Pharma With Game-Changing $14.5 Billion Deal    More...

Billionaire Ackman, Valeant Pharmaceuticals International (VRX) Team Up To Make $45.6 Billion Allergan Inc. (AGN) Bid    More...

Potential Impact On R&D If Pfizer Inc. (PFE) Succeeds In Taking Over AstraZeneca PLC (AZN)    More...

Pfizer Inc. (PFE) Cautiously Approaches Strained AstraZeneca PLC (AZN) With $101 Billion Buyout Deal    More...

Bay Area's Principia Biopharma Secures $50 Million Series B Financing    More...

Pfizer Inc. (PFE) Shows Off Top Data For Two Phase 3 Psoriasis Trials    More...

AbbVie (ABBV) Moving Up To 2,000 Workers Off Abbott Laboratories (ABT) Campus    More...

FDA Approves Eli Lilly and Company (LLY)'s Cyramza For Stomach Cancer    More...

Menlo Park's Avalanche Biotechnologies Secures $55 Million    More...

Your Menstrual Cycle Exposed: 6 Things Your Period Can Tell You About Your Health    More...

 
More News

Did Chimerix, Inc. Set A Bad Example For Biopharma? </b>Did Chimerix, Inc. Set A Bad Example For Biopharma?

Chimerix generated some pretty negative publicity when it denied a dying seven-year old boy access to its experimental drug brincidofovir. Josh Hardy had developed an adenovirus infection following a bone marrow transplant related to past cancer treatment. Since Chimerix has a drug that has demonstrated some efficacy (albeit much of it anecdotal) in exactly this indication, doctors recommended the parents see about getting the medicine on a "compassionate use" basis. The company, however, demurred. More...
Executive Jobs
DepomedChief Medical Officer
CelgeneVice President, Global Medical Affairs
Novartis Institutes for BioMedical ResearchGlobal HR Partner, Executive Director
HospiraMedical Director, Biologics Medical Affairs

Search Jobs


Miles
Km80.5


 
Money May Carry 3,000 Different Types Of Bacteria, New York University Reveals    More...
Billionaire Outs Valeant Pharmaceuticals International (VRX) CEO As A Billionaire    More...
With Big Pharma Failing, Ackman And Novartis AG (NVS) Try A New Blueprint For Drug Companies    More...
How Big Pharma Holds Back In The War On Cancer    More...
Puzzling Rare Birth Defects Hit Washington State    More...
Protein That Shrinks Depressed Brains Identified, Yale University Study    More...
High-Fat Diets Linked To CertainTypes Of Breast Cancer, Fondazione IRCCS National Cancer Institute Study    More...
Can You Sleep Away Your Infection? University of Pennsylvania Study    More...
 
More Featured News


 

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.


Show me jobs for this employer
 
Feature Employer
 
Emerging Job Search Trends In 2014    More...

Hiring Managers Reveal The 15 BEST Words To Use On Your Resume    More...

10 Interview Questions; The Good, Bad, And The Ugly    More...

What Your Body Language Is Saying During The Interview    More...

The 2 Stages Of Job Search Rejection    More...

5 Resume Errors That Will Land You In The Trash    More...

5 Rules Of Employment Follow-Up    More...

3 Executive Resume Bloopers You’re Making Right Now    More...

3 Secrets To Interview-Winning Cover Letters    More...

6 Ways To Handle Irritating Colleagues    More...

 
More Career Tips



//-->